FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183820020> ?p ?o ?g. }

• W2183820020 endingPage "5" @default.
• W2183820020 startingPage "270" @default.
• W2183820020 abstract "The limitations of antipsychotics for treatment of schizophrenia have led to investigation of the usefulness of pharmacological augmentation strategies. Clinical studies have provided evidence for glutamate abnormalities in schizophrenia. Topiramate is an anticonvulsant drug with alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist properties; therefore, the objective of the present study was to explore the therapeutic efficacy of topiramate as an adjunctive medication in schizophrenia.A 17 week, double-blind, placebo-controlled clinical trial was performed on 80 patients (25 - 65 years) from 2005 - 2007. All were hospitalized in Mashhad psychiatric hospitals with chronic DSM-IV-TR-diagnosed schizophrenia. All participants received up to 300 mg/day of clozapine. In addition, participants randomly received either topiramate (200 - 300 mg/day) or placebo gradually added to their ongoing treatment. Efficacy of medication was measured by administering Positive and Negative Syndrome Scale at baseline and weeks 4, 8, 12, and 17.During the study, 5 patients from the placebo group and 12 participants from topiramate group were excluded. Clozapine and topiramate group showed significant decreases in all three subscales of PANSS values from baseline, with the maximum efficacy in week 12. However, after tapering topiramate, the general psychopathology sign was the only subscale that showed a significant difference. The clozapine and placebo group showed a significant decrease in all three subscales of PANSS values compared to baseline. The significant efficacy for all subscales was obtained at the end point. No significant differences in PANSS scores from baseline to end point were noted between case and control groups.Augmentation of clozapine and topiramate did not significantly decline patterns in any of the three subscales of PANSS compared to the clozapine and placebo group. Irct ID: IRCT138904014236N1" @default.
• W2183820020 created "2016-06-24" @default.
• W2183820020 creator A5020317255 @default.
• W2183820020 creator A5029345868 @default.
• W2183820020 creator A5057193527 @default.
• W2183820020 creator A5067470436 @default.
• W2183820020 creator A5091297988 @default.
• W2183820020 date "2011-07-01" @default.
• W2183820020 modified "2023-09-23" @default.
• W2183820020 title "Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial." @default.
• W2183820020 cites W1531379989 @default.
• W2183820020 cites W1574289536 @default.
• W2183820020 cites W1967012491 @default.
• W2183820020 cites W1976480751 @default.
• W2183820020 cites W1982321740 @default.
• W2183820020 cites W1984571809 @default.
• W2183820020 cites W1987047506 @default.
• W2183820020 cites W1988714288 @default.
• W2183820020 cites W1996015681 @default.
• W2183820020 cites W2003904508 @default.
• W2183820020 cites W2005266186 @default.
• W2183820020 cites W2011550275 @default.
• W2183820020 cites W2014555657 @default.
• W2183820020 cites W2022707658 @default.
• W2183820020 cites W2027892169 @default.
• W2183820020 cites W2041045231 @default.
• W2183820020 cites W2041144669 @default.
• W2183820020 cites W2045122066 @default.
• W2183820020 cites W2051186633 @default.
• W2183820020 cites W2059465717 @default.
• W2183820020 cites W2061629536 @default.
• W2183820020 cites W2065484560 @default.
• W2183820020 cites W2067613371 @default.
• W2183820020 cites W2073929631 @default.
• W2183820020 cites W2076385317 @default.
• W2183820020 cites W2086593869 @default.
• W2183820020 cites W2091038866 @default.
• W2183820020 cites W2114024409 @default.
• W2183820020 cites W2120341782 @default.
• W2183820020 cites W2130494039 @default.
• W2183820020 cites W2142914211 @default.
• W2183820020 cites W2162961854 @default.
• W2183820020 cites W2195324906 @default.
• W2183820020 cites W3149245474 @default.
• W2183820020 cites W2520602388 @default.
• W2183820020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21726104" @default.
• W2183820020 hasPublicationYear "2011" @default.
• W2183820020 type Work @default.
• W2183820020 sameAs 2183820020 @default.
• W2183820020 citedByCount "7" @default.
• W2183820020 countsByYear W21838200202013 @default.
• W2183820020 countsByYear W21838200202014 @default.
• W2183820020 countsByYear W21838200202015 @default.
• W2183820020 countsByYear W21838200202016 @default.
• W2183820020 countsByYear W21838200202021 @default.
• W2183820020 crossrefType "journal-article" @default.
• W2183820020 hasAuthorship W2183820020A5020317255 @default.
• W2183820020 hasAuthorship W2183820020A5029345868 @default.
• W2183820020 hasAuthorship W2183820020A5057193527 @default.
• W2183820020 hasAuthorship W2183820020A5067470436 @default.
• W2183820020 hasAuthorship W2183820020A5091297988 @default.
• W2183820020 hasConcept C118552586 @default.
• W2183820020 hasConcept C126322002 @default.
• W2183820020 hasConcept C142724271 @default.
• W2183820020 hasConcept C15744967 @default.
• W2183820020 hasConcept C204787440 @default.
• W2183820020 hasConcept C27081682 @default.
• W2183820020 hasConcept C2776412080 @default.
• W2183820020 hasConcept C2777683783 @default.
• W2183820020 hasConcept C2778186239 @default.
• W2183820020 hasConcept C2779727114 @default.
• W2183820020 hasConcept C2780135775 @default.
• W2183820020 hasConcept C2780864610 @default.
• W2183820020 hasConcept C42219234 @default.
• W2183820020 hasConcept C71924100 @default.
• W2183820020 hasConceptScore W2183820020C118552586 @default.
• W2183820020 hasConceptScore W2183820020C126322002 @default.
• W2183820020 hasConceptScore W2183820020C142724271 @default.
• W2183820020 hasConceptScore W2183820020C15744967 @default.
• W2183820020 hasConceptScore W2183820020C204787440 @default.
• W2183820020 hasConceptScore W2183820020C27081682 @default.
• W2183820020 hasConceptScore W2183820020C2776412080 @default.
• W2183820020 hasConceptScore W2183820020C2777683783 @default.
• W2183820020 hasConceptScore W2183820020C2778186239 @default.
• W2183820020 hasConceptScore W2183820020C2779727114 @default.
• W2183820020 hasConceptScore W2183820020C2780135775 @default.
• W2183820020 hasConceptScore W2183820020C2780864610 @default.
• W2183820020 hasConceptScore W2183820020C42219234 @default.
• W2183820020 hasConceptScore W2183820020C71924100 @default.
• W2183820020 hasIssue "4" @default.
• W2183820020 hasLocation W21838200201 @default.
• W2183820020 hasOpenAccess W2183820020 @default.
• W2183820020 hasPrimaryLocation W21838200201 @default.
• W2183820020 hasRelatedWork W14678275 @default.
• W2183820020 hasRelatedWork W1845331805 @default.
• W2183820020 hasRelatedWork W1957187487 @default.
• W2183820020 hasRelatedWork W1970908493 @default.
• W2183820020 hasRelatedWork W1971001319 @default.

• next